Why Are Tyme Technologies Shares Staring At 52-Week Low
January 26, 2022 at 07:25 AM EST
TYME Technologies Inc(NASDAQ: TYME) will discontinue SM-88 with MPS in the Precision Promise trial in metastatic pancreatic cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.